Mesoblast Limited (MSB) Stock Statistics & Valuation Metrics

Mesoblast Limited has a market cap or net worth of $2.94B. The enterprise value is AU$2.05B.

Mesoblast Limited has 1,279,967,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesoblast Limited’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -8.48%.

The current PE Ratio of Mesoblast Limited is ―. Mesoblast Limited’s PEG ratio is ―.

In the last 12 months, Mesoblast Limited had revenue of 17.20M and earned -102.14M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was -20.66M and capital expenditures -233.00K, giving a free cash flow of -21.07M billion.

Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Mesoblast Limited upcoming earnings date is Feb 26, 2026, TBA (Confirmed).

Mesoblast Limited as a current ratio of 1.99, with Debt / Equity ratio of 21.45%

In the past 12 months, Mesoblast Limited has paid 330.00K in taxes.

Mesoblast Limited EV to EBITDA ratio is 0.45, with an EV/FCF ratio of 0.65.

Mesoblast Limited has $38.03M in cash and marketable securities with $126.11M in debt, giving a net cash position of -$88.08M billion.

Gross margin is -398.00%, with operating margin of -363.08%, and net profit margin of -593.92%.

The average price target for Mesoblast Limited is $3.03, which is 11.43% higher than the current price. The consensus rating is Moderate Buy